Characterization of the N-acetylaspartate biosynthetic enzyme from rat brain.
Aspartate N-acetyltransferase (Asp-NAT; EC 2.3.1.17) activity was found in highly purified intact mitochondria prepared by Percoll gradient centrifugation as well as in the three subfractions obtained after the sucrose density gradient centrifugation of Percoll purified mitochondria; citrate synthase was used as a marker enzyme for mitochondria. The proportion of recoverable activities of Asp-NAT and citrate synthase were comparable in mitochondrial and synaptosomal fractions but not in the fraction containing myelin. Asp-NAT was solubilized from the pellet of the rat brain homogenate (26 000 g for 1 h) for the recovery of maximum activity and partially purified using three protein separation methods: DEAE anion exchange chromatography, continuous elution native gel electrophoresis and size-exclusion high performance liquid chromatography. Asp-NAT activity and the optical density pattern of the eluted protein from size-exclusion column indicated a single large protein (approximately 670 kDa), which on sodium dodecyl sulfate-polyacrylamide gel electrophoresis showed at least 10 bands indicative of an enzyme complex. This seemingly multi-subunit complex Asp-NAT was stable towards ionic perturbations but vulnerable to hydrophobic perturbation; almost 95% of activity was lost after 10 mm 3-[(3-cholamidopropyl)dimethylammonia]-1-propanesulfonate (CHAPS) treatment followed by size-exclusion chromatography. Asp-NAT showed an order of magnitude difference in Km between l-aspartate (l-Asp, approximately 0.5 mm) and acetyl CoA (approximately 0.05 mm). Asp-NAT showed high specificity towards l-Asp with 3% or less activity towards l-Glu, l-Asn, l-Gln and Asp-Glu. A model on the integral involvement of NAA synthesis in the energetics of neuronal mitochondria is proposed.
Madhavarao
C N
CN
Department of Anatomy, Physiology and Genetics, Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA.
Chinopoulos
C
C
Chandrasekaran
K
K
Namboodiri
M A A
MA
D000105:Acetyl Coenzyme A / Q000737:chemistry; D000123:Acetyltransferases / Q000737:chemistry* / Q000302:isolation & purification; D000818:Animals; D001224:Aspartic Acid / Q000031:analogs & derivatives* / Q000737:chemistry / Q000378:metabolism / Q000494:pharmacology; D001921:Brain / Q000201:enzymology*; D001923:Brain Chemistry; D002499:Centrifugation, Density Gradient; D002793:Cholic Acids / Q000494:pharmacology; D002850:Chromatography, Gel; D002851:Chromatography, High Pressure Liquid; D002855:Chromatography, Thin Layer; D004734:Energy Metabolism; D004789:Enzyme Activation / Q000187:drug effects; D005260:Female; D046911:Macromolecular Substances; D008297:Male; D008928:Mitochondria / Q000737:chemistry / Q000201:enzymology; D008970:Molecular Weight; D051381:Rats; D017207:Rats, Sprague-Dawley; D013347:Subcellular Fractions / Q000737:chemistry / Q000201:enzymology; D013379:Substrate Specificity
D002793:Cholic Acids; D046911:Macromolecular Substances; D001224:Aspartic Acid; D000105:Acetyl Coenzyme A; C000179:N-acetylaspartate; D000123:Acetyltransferases; C046791:aspartate N-acetyltransferase; C028213:3-((3-cholamidopropyl)dimethylammonium)-1-propanesulfonate